Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Debt / NOTE 2.250%12/1
-
Market price (% of par)
-
96.26%
-
Total 13F principal
-
$18,045,513
-
Principal change
-
+$104,000
-
Total reported market value
-
$17,376,000
-
Number of holders
-
10
-
Value change
-
+$101,000
-
Number of buys
-
1
Institutional Holders of ENDOLOGIX INC - NOTE 2.250%12/1 as of Q4 2017
As of 31 Dec 2017,
ENDOLOGIX INC - NOTE 2.250%12/1 was held by
10 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$18,045,513
in principal (par value) of the bond.
The largest 10 bondholders included
AMUNDI PIONEER ASSET MANAGEMENT INC, CITADEL ADVISORS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, SSI INVESTMENT MANAGEMENT INC, Endurant Capital Management LP, ADVENT CAPITAL MANAGEMENT /DE/, Bank of New York Mellon Corp, WOLVERINE ASSET MANAGEMENT LLC, MORGAN STANLEY, and STIFEL FINANCIAL CORP.
This page lists
10
institutional bondholders reporting positions
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.